reviewThe OncologistOct 1, 2005BRONZE OA

Extending Survival with Chemotherapy in Metastatic Breast Cancer

Texas Oncology

PubMed
Indexed incrossrefdoajpubmed

Abstract

Abstract Learning Objectives After completing this course, the reader will be able to: Identify trials that have demonstrated a survival benefit with a modern chemotherapeutic agent or regimen in MBC.Summarize recent findings of randomized trials showing survival benefits with targeted therapy–chemotherapy combinations in MBC.Discuss quality-of-life findings and their implications in clinical practice. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com Metastatic breast cancer (MBC) remains essentially incurable, and goals of therapy include the palliation of symptoms, delay of disease progression, and prolongation of overall survival time without negatively…

Citation impact

678
total citations
FWCI
4.95
Percentile
100%
References
44
Citations per year

Authors

1

Topics & keywords

Keywords
  • Medicine
  • Taxane
  • Metastatic breast cancer
  • Oncology
  • Trastuzumab
  • Internal medicine
  • Bevacizumab
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.